Vig Pamela 4
4 · Mirum Pharmaceuticals, Inc. · Filed Oct 1, 2021
Insider Transaction Report
Form 4
Vig Pamela
Chief Scientific Officer
Transactions
- Award
Common Stock
2021-09-29+8,125→ 11,031 total - Sale
Common Stock
2021-10-01$19.26/sh−1,364$26,265→ 9,667 total
Holdings
- 75,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The shares became issuable upon the satisfaction of certain performance conditions that were established at the time of the Compensation Committee's approval of a performance-based restricted stock unit award on March 9, 2021. On September 29, 2021, the Compensation Committee certified the achievement of the performance criteria resulting in the vesting of 4,062 shares on September 29, 2021 and 4,063 shares on June 30, 2023.
- [F2]Shares sold to cover tax withholding obligations associated with the vesting of the performance-based restricted stock unit award granted to the Reporting Person on March 9, 2021.